首页> 美国卫生研究院文献>ISRN Hematology >Regulation of Immune Responses by Histone Deacetylase Inhibitors
【2h】

Regulation of Immune Responses by Histone Deacetylase Inhibitors

机译:组蛋白脱乙酰基酶抑制剂对免疫反应的调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Both genetic and epigenetic factors are important regulators of the immune system. There is an increasing body of evidence attesting to epigenetic modifications that influence the development of distinct innate and adaptive immune response cells. Chromatin remodelling via acetylation, methylation, phosphorylation, and ubiquitination of histone proteins as well as DNA, methylation is epigenetic mechanisms by which immune gene expression can be controlled. In this paper, we will discuss the role of epigenetics in the regulation of host immunity, with particular emphasis on histone deacetylase inhibitors. In particular, the role of HDAC inhibitors as a new class of immunomodulatory therapeutics will also be reviewed.
机译:遗传因素和表观遗传因素都是免疫系统的重要调节剂。越来越多的证据证明表观遗传修饰会影响不同的先天和适应性免疫反应细胞的发育。通过组蛋白和DNA的乙酰化,甲基化,磷酸化和泛素化来染色质重塑,甲基化是表观遗传机制,可通过该机制控制免疫基因的表达。在本文中,我们将讨论表观遗传学在调节宿主免疫力中的作用,尤其着重于组蛋白脱乙酰基酶抑制剂。特别地,还将对HDAC抑制剂作为一类新的免疫调节疗法的作用进行综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号